|
|
|
|
| LEADER |
01385cam a2200361 4500 |
| 001 |
PPN019803729 |
| 005 |
20200625055200.0 |
| 035 |
|
|
|a ocm14385846
|
| 035 |
|
|
|a ocm07508945
|
| 100 |
|
|
|a 19770811d1976 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a GB
|
| 105 |
|
|
|a y z 100yy
|
| 106 |
|
|
|a r
|
| 200 |
0 |
|
|a Pharmacological and clinical aspects of bromocriptine (Parlodel)
|b Texte imprimé
|e proceedings of a symposium held at the Royal College of Physicians, London, 14 May, 1976
|f editors, R. I. S. Bayliss, P. Turner, W. P. Maclay
|
| 210 |
|
|
|a Tunbridge Wells, Eng.
|c MCS Consultants
|d cop. 1976
|
| 215 |
|
|
|a 1 vol. (117 p.)
|c ill.
|
| 300 |
|
|
|a Sponsored by Sandoz
|
| 606 |
|
|
|3 PPN040702022
|a Ergolines
|3 PPN040685969
|x Congrès
|2 fmesh
|
| 606 |
|
|
|3 PPN040673766
|a Bromocriptine
|3 PPN040685969
|x Congrès
|2 fmesh
|
| 606 |
|
|
|3 PPN031449654
|a Bromocriptine
|3 PPN02886431X
|x Congrès
|2 rameau
|
| 686 |
|
|
|a QV 174
|b P536 1976
|2 usnlm
|
| 686 |
|
|
|a QV174 P45
|2 usnlm
|
| 702 |
|
1 |
|3 PPN113743149
|a Bayliss
|b Richard
|c 1917-2006
|4 651
|
| 702 |
|
1 |
|3 PPN080260349
|a Turner
|b Paul
|4 651
|
| 702 |
|
1 |
|3 PPN113743211
|a Maclay
|b W. P.
|4 651
|
| 712 |
0 |
2 |
|3 PPN085827118
|a Royal college of physicians
|c GB
|4 557
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20070404
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 930 |
|
|
|5 441092101:303938684
|b 441092101
|a 55086
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 305700
|
Nantilus
